ARROWHEAD PHARMACEUTICALS, INC. Shares Outstanding (Cover Page)
ARROWHEAD PHARMACEUTICALS, INC. (ARWR) had Shares Outstanding (Cover Page) of 141.25 million shares as of 2026-07-30, per its 10-Q filed 2026-08-04.
Financial Statements › Notes › Cover Page
dei:EntityCommonStockSharesOutstanding · last filed 2026-08-04
- 2026-07-30: Entity Common Stock, Shares Outstanding 141.25M shares.
- 2026-05-01: Entity Common Stock, Shares Outstanding 140.86M shares.
- 2026-01-30: Entity Common Stock, Shares Outstanding 140.03M shares.
- 2025-11-19: Entity Common Stock, Shares Outstanding 135.81M shares.
| Period end | Entity Common Stock, Shares Outstanding |
|---|---|
| 2026-07-30 | 141.25M shares 10-Q · filed 2026-08-04 |
| 2026-05-01 | 140.86M shares 10-Q · filed 2026-05-07 |
| 2026-01-30 | 140.03M shares 10-Q · filed 2026-02-05 |
| 2025-11-19 | 135.81M shares 10-K · filed 2025-11-25 |
| 2025-08-01 | 138.26M shares 10-Q · filed 2025-08-07 |
| 2025-05-01 | 138.10M shares 10-Q · filed 2025-05-12 |
| 2025-02-03 | 126.10M shares 10-Q · filed 2025-02-10 |
| 2024-11-20 | 124.43M shares 10-K/A · filed 2025-10-10 |
| 2024-08-01 | 124.32M shares 10-Q · filed 2024-08-08 |
| 2024-05-01 | 124.20M shares 10-Q · filed 2024-05-09 |
| 2024-01-31 | 123.90M shares 10-Q · filed 2024-02-06 |
| 2023-11-20 | 107.43M shares 10-K · filed 2023-11-29 |
| 2023-07-31 | 107.19M shares 10-Q · filed 2023-08-07 |
| 2023-04-24 | 106.90M shares 10-Q · filed 2023-05-02 |
| 2023-02-01 | 108.31M shares 10-Q · filed 2023-02-06 |
| 2022-11-16 | 106.01M shares 10-K · filed 2022-11-28 |
| 2022-07-28 | 105.85M shares 10-Q · filed 2022-08-04 |
| 2022-05-05 | 105.74M shares 10-Q · filed 2022-05-10 |
| 2022-01-31 | 105.46M shares 10-Q · filed 2022-02-02 |
| 2021-11-15 | 104.53M shares 10-K · filed 2021-11-22 |
| 2021-08-02 | 104.26M shares 10-Q · filed 2021-08-05 |
| 2021-04-30 | 104.08M shares 10-Q · filed 2021-05-04 |
| 2021-02-01 | 103.79M shares 10-Q · filed 2021-02-04 |
| 2020-11-16 | 102.76M shares 10-K · filed 2020-11-23 |
| 2020-07-27 | 102.29M shares 10-Q · filed 2020-08-05 |
| 2020-05-05 | 101.77M shares 10-Q · filed 2020-05-07 |
| 2020-02-03 | 101.65M shares 10-Q · filed 2020-02-05 |
| 2019-11-20 | 95.71M shares 10-K · filed 2019-11-25 |
| 2019-08-02 | 95.30M shares 10-Q · filed 2019-08-05 |
| 2019-05-06 | 94.81M shares 10-Q · filed 2019-05-08 |
| 2019-02-06 | 94.21M shares 10-Q · filed 2019-02-07 |
| 2018-12-07 | 92.22M shares 10-K · filed 2018-12-11 |
| 2018-08-06 | 88.02M shares 10-Q · filed 2018-08-07 |
| 2018-05-07 | 87.58M shares 10-Q · filed 2018-05-08 |
| 2018-02-07 | 86.79M shares 10-Q · filed 2018-02-09 |
| 2017-12-06 | 74.83M shares 10-K · filed 2017-12-12 |
| 2017-08-01 | 74.77M shares 10-Q · filed 2017-08-03 |
| 2017-05-02 | 74.77M shares 10-Q · filed 2017-05-03 |
| 2017-02-03 | 74.57M shares 10-Q · filed 2017-02-06 |
| 2016-12-12 | 74.17M shares 10-K · filed 2016-12-14 |
| 2016-08-08 | 60.75M shares 10-Q · filed 2016-08-09 |
| 2016-05-09 | 59.96M shares 10-Q · filed 2016-05-10 |
| 2016-02-05 | 59.63M shares 10-Q · filed 2016-02-09 |
| 2015-12-11 | 59.55M shares 10-K · filed 2015-12-14 |
| 2015-07-31 | 59.50M shares 10-Q · filed 2015-08-04 |
| 2015-05-08 | 59.50M shares 10-Q · filed 2015-05-11 |
| 2015-02-05 | 54.79M shares 10-Q · filed 2015-02-09 |
| 2014-11-24 | 54.68M shares 10-K · filed 2014-11-25 |
| 2014-08-11 | 52.91M shares 10-Q · filed 2014-08-12 |
| 2014-05-01 | 51.87M shares 10-Q · filed 2014-05-06 |
| 2014-01-31 | 39.69M shares 10-Q · filed 2014-02-04 |
| 2013-12-16 | 38.70M shares 10-K · filed 2013-12-18 |
| 2013-08-05 | 31.54M shares 10-Q · filed 2013-08-07 |
| 2013-05-07 | 31.31M shares 10-Q · filed 2013-05-09 |
| 2013-02-08 | 17.31M shares 10-Q · filed 2013-02-13 |
| 2012-12-21 | 15.64M shares 10-K · filed 2012-12-28 |
| 2012-08-03 | 11.31M shares 10-Q · filed 2012-08-13 |
| 2012-05-01 | 11.21M shares 10-Q · filed 2012-05-08 |
| 2012-02-01 | 10.53M shares 10-Q · filed 2012-02-09 |
| 2011-12-15 | 10.53M shares 10-K · filed 2011-12-20 |
| 2011-08-01 | 71.83M shares 10-Q · filed 2011-08-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 |